Latest News in the pharma Industry

Biopharma News

PnuVax awarded $29.4 million grant to advance innovative vaccine into clinical trials

PnuVax awarded $29.4 million grant to advance innovative vaccine into clinical trials

2 Oct 2017

Use of PnuVax’s unique patented conjugation platform technology to produce the vaccine is expected to speed up biomanufacturing and increase yield for a greatly reduced per-dose cost.

Read more 
3SBio accelerates expansion of its global biologics platform

3SBio accelerates expansion of its global biologics platform

3 Sep 2017

The Chinese biopharmaceutical company acquires the Canadian biomanufacturing business of Therapure.

Read more 
Bayer submits BLA in the for BAY94-9027 – a long-acting factor VIII for the treatment of hemophilia A

Bayer submits BLA in the for BAY94-9027 – a long-acting factor VIII for the treatment of hemophilia A

3 Sep 2017

Pivotal studies with BAY94-9027 showed that bleed protection was achieved with extended dosing intervals.

Read more 
Merck successfully closes biosimilars transaction

Merck successfully closes biosimilars transaction

1 Sep 2017

Step towards strategic alignment of R&D resources to Healthcare priorities.

Read more 
Biogen’s adalimumab biosimilar referencing Humira, is approved in the EU

Biogen’s adalimumab biosimilar referencing Humira, is approved in the EU

28 Aug 2017

Biogen becomes the first company with approved biosimilars for the three most prescribed anti-TNF biologic treatments in Europe.

Read more 
Boehringer Ingelheim receives FDA approval for its Humira biosimilar

Boehringer Ingelheim receives FDA approval for its Humira biosimilar

29 Aug 2017

Cyltezo approved for the treatment of multiple chronic inflammatory diseases.

Read more 
Biopharma stages a strong recovery over the first half even as M&A deals disappoint

Biopharma stages a strong recovery over the first half even as M&A deals disappoint

4 Aug 2017

EP Vantage releases half-year reviews of pharma & biotech and medtech performance.

Read more 
Amgen submits sBLA for Prolia in glucocorticoid-induced osteoporosis

Amgen submits sBLA for Prolia in glucocorticoid-induced osteoporosis

31 Jul 2017

Results from the Phase III study included in the sBLA submission showed that treatment with Prolia for 12 months led to statistically significant greater gains in BMD at the lumbar spine and total hip compared to risedronate.

Read more 
Boehringer starts clinical study on interchangeability between adalimumab biosimilar candidate and US-formulated Humira

Boehringer starts clinical study on interchangeability between adalimumab biosimilar candidate and US-formulated Humira

30 Jul 2017

First study in the US to investigate an interchangeability designation for an adalimumab biosimilar candidate.

Read more 
Pall introduces proprietary bioreactor control system

Pall introduces proprietary bioreactor control system

27 Jul 2017

The mPath bioreactor control system is the first to be developed and delivered by a technology supplier specifically for their product line, allowing full access to bioreactor capabilities that current commercial solutions cannot provide.

Read more 
Valeant launches Siliq Injection in US

Valeant launches Siliq Injection in US

27 Jul 2017

Dermatology unit is rebranded Ortho Dermatologics.

Read more 
Merck launches Remicade biosimilar for all eligible indications, in the US

Merck launches Remicade biosimilar for all eligible indications, in the US

24 Jul 2017

The biosimilar's list price will represent a 35% discount to the current list price of Remicade.

Read more